Pursuant to Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Venmax Drugs & Pharmaceuticals has informed that it enclosed the Un-audited Standalone Financial Results along with Limited Review Report of the Statutory Auditors of the company, PPKG & Co Chartered Accountants for the quarter ended 30th June, 2025. The Financial Results are also available on the website of the Company at www.venmaxdrugs.com and on the website of BSE www.bseindia.com. The Board Meeting commenced at 02:00 pm and concluded at 03:20 pm.
The above information is a part of company’s filings submitted to BSE.
